Results 231 to 240 of about 202,817 (273)

The incidence and risk factor of atrial fibrillation after percutaneous coronary intervention. [PDF]

BMC Cardiovasc Disord
Su S, Li L, Peng X, Zhou L, Xiong Y, Zhang Z, Yao Y.   +6 more
europepmc   +1 more source

Incidence and Risk Factors of Limb Ischaemia in Adult Patients Receiving Veno‐Arterial Extracorporeal Membrane Oxygenation: A Systematic Review and Meta‐Analysis

Nursing in Critical Care, Volume 31, Issue 2, March 2026.
ABSTRACT Background Limb ischaemia is a serious and potentially limb‐threatening vascular complication associated with veno‐arterial extracorporeal membrane oxygenation (V‐A ECMO). However, substantial heterogeneity has been observed in the reported incidence rates and identified risk factors among published studies.
Meiqian Guo, Mengyao Ji, Jiayuan Qu, Chuanxiang Yuan, Peixi Wang   +4 more
wiley   +1 more source

Percutaneous Coronary Intervention or Medical Therapy for Chronic Total Occlusion in Older Adults. [PDF]

JACC Adv
Jamil Y, Dermksian M, El Ghazawi A, Damara FA, Augustine A, Walgamage M, Frampton J, Grimshaw AA, Park DY, Akman Z, Mouslmani M, Nouri A, Babapour G, Rossi R, Kochar A, Curtis J, Tehrani B, Batchelor WB, Sherwood MW, Damluji AA, Nanna MG.   +20 more
europepmc   +1 more source

Induction of ischaemic cardiomyopathy in mice without off‐target effects

Experimental Physiology, EarlyView.
Mark T. Waddingham, James T. Pearson
wiley   +1 more source

Long‐term amyloid PET and MRI outcomes in a menopausal hormone therapy trial

Alzheimer's &Dementia, Volume 22, Issue 2, February 2026.
Abstract INTRODUCTION Associations of short‐term use of menopausal hormone therapy (mHT) with Alzheimer's disease (AD) and structural magnetic resonance imaging (MRI) biomarkers were investigated 10 years after an mHT trial. METHODS Recently menopausal women with good cardiovascular health were randomized to oral conjugated equine estrogens (oCEE) or ...
Kejal Kantarci, Firat Kara, Nirubol Tosakulwong, Angela J. Fought, Christopher G. Schwarz, Matthew L. Senjem, June Kendall‐Thomas, Paul Min, Val J. Lowe, Clifford R. Jack, Ekta Kapoor, Julie A. Fields, Kent R. Bailey, Taryn T. James, Laura Faubion, Rogerio A. Lobo, JoAnn E. Manson, Lubna Pal, Dustin B. Hammers, Eliot A. Brinton, Michael Malek‐Ahmadi, Marcelle I. Cedars, Frederick N. Naftolin, Nanette Santoro, Virginia M. Miller, Sherman M. Harman, N. Maritza Dowling, Carey E. Gleason   +27 more
wiley   +1 more source

Prognostic Implications of Hemoglobin Drop With and Without Overt Bleeding After Percutaneous Coronary Intervention. [PDF]

JACC Asia
Suzuki T, Kohsaka S, Shoji S, Shiraishi Y, Sawano M, Ohata T, Yoneoka D, Asano T, Nakamaru R, Noma S, Ueda I, Numasawa Y, Ieda M.   +12 more
europepmc   +1 more source

Implantable Drug Delivery Systems for Skeletal Muscles and Eyes

Advanced NanoBiomed Research, Volume 6, Issue 2, February 2026.
This review highlights the different types of recent implantable drug delivery systems (IDDS) fabricated for a use with skeletal muscles, and with eyes. It presents the developments already made and the current research directions, showing the evolution of IDDS and their great diversity.
Serge Ostrovidov, Murugan Ramalingam, Hongkai Wu, Toshinori Fujie, Yukinari Nakamura, Takeshi Hori, Yuji Nashimoto, Xuetao Shi, Hirokazu Kaji   +8 more
wiley   +1 more source

Success in Reducing Acute Kidney Injury Post-Percutaneous Coronary Intervention. [PDF]

JACC Case Rep
Anthuvan J, Blake P, Blais D, Lima J, Logan D, Boudoulas KD.   +5 more
europepmc   +1 more source

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 329-347, February 2026.
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo, Iain Frater, Rebecca Kuruvilla, Stefanie Lip, Hannah O'Neill, Kerry Burke, Vicky Chaplin, Alexander S. F. Doney, Salim Elyas, Nicholas Greaves, Sophie Harding, David Hargroves, Judith Hayward, Dyfrig A. Hughes, Tom A. T. Hughes, Sree Kondapally, Patrick Mok, Aaron Peace, Imran Rafi, Simon Ray, Vicky Stinton, Luigi Venetucci, Munir Pirmohamed   +22 more
wiley   +1 more source

Antithrombotic Management in Patients With Atrial Fibrillation Following Percutaneous Coronary Intervention: An Updated Clinical Review. [PDF]

J Arrhythm
Saito Y, Kobayashi Y.
europepmc   +1 more source